Cargando…
Role of dexamethasone dosage in combination with 5-HT(3) antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting
Dexamethasone (20 mg) or its equivalent in combination with 5-HT(3) antagonists appears to be the gold-standard dose for antiemetic prophylaxis. Additional to concerns about the use of corticosteroids with respect to enhanced tumour growth or impaired killing of the tumour cells, there is evidence t...
Autores principales: | Münstedt, K, Müller, H, Blauth-Eckmeyer, E, Stenger, K, Zygmunt, M, Vahrson, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362432/ https://www.ncbi.nlm.nih.gov/pubmed/10027342 http://dx.doi.org/10.1038/sj.bjc.6690100 |
Ejemplares similares
-
Role of pre-operative dexamethasone as prophylaxis for postoperative nausea and vomiting in laparoscopic surgery
por: Gupta, P, et al.
Publicado: (2006) -
Granisetron Versus Dexamethasone in Prophylaxis of Nausea and Vomiting After Laparoscopic Cholecystectomy
por: Hessami, Mohammad Ali, et al.
Publicado: (2012) -
Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study
por: Ma, Yijie, et al.
Publicado: (2022) -
Impact of 5-HT(3) receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study
por: Lin, Swu-Jane, et al.
Publicado: (2012) -
COVID‐19, nausea, and vomiting
por: Andrews, Paul L R, et al.
Publicado: (2020)